Funded Startups in Labège
Labège’s most recent disclosed rounds span from 2020-11-17 (Declique, $300K) to 2023-12-12 (Antabio, $27M), a range of roughly three years.
Labège’s most recent disclosed rounds span from 2020-11-17 (Declique, $300K) to 2023-12-12 (Antabio, $27M), a range of roughly three years. The size distribution is sharply uneven: Antabio’s $27M Series B in 2023-12-12 dwarfs the next-largest disclosed rounds (EyeLights at $22M on 2023-04-12 and Alteia at $17M on 2021-12-01), while the smallest disclosed round shown is Declique’s $300K on 2020-11-17.
Date clustering is also visible among the newest entries: three rounds between 2023-04-12 and 2023-12-12 (EyeLights $22M, MerciYanis $3M, Antabio $27M). Sector-wise, three of the five companies are in adjacent “deep tech/product” categories (Biotechnology: Antabio; Consumer Electronics: EyeLights; AI: Alteia), and two rows share the same broad geography naming with all five entries located in Labège, Midi-Pyrenees, France.
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Labège here, and how does it compare to the rest?
Antabio’s $27M (Series B) closed on 2023-12-12, which dwarfs the next-largest disclosed amount: EyeLights at $22M on 2023-04-12; after that, Alteia is $17M on 2021-12-01, while the smallest disclosed round is Declique’s $300K on 2020-11-17.
Are the most recent rounds clustered into a narrow time window?
Yes. Three of the five disclosed rounds fall between 2023-04-12 and 2023-12-12: EyeLights ($22M), MerciYanis ($3M), and Antabio ($27M). By contrast, the remaining two rounds are older—Alteia ($17M) on 2021-12-01 and Declique ($300K) on 2020-11-17.
Which stages dominate this small set, and where is the stage “unknown” pattern?
Three of the five entries have explicit stage labels (Antabio Series B; MerciYanis Series A; EyeLights Series A). Alteia is listed as Debt Financing ($17M) on 2021-12-01, and Declique (2020-11-17) has an empty stage classification with a disclosed amount of $300K.
Are there sector concentrations worth checking beyond “Labège” as a location?
The sectors skew toward applied tech/product categories rather than services-heavy labels: Antabio is Biotechnology ($27M on 2023-12-12), EyeLights is Consumer Electronics ($22M on 2023-04-12), and Alteia is AI ($17M on 2021-12-01). The remaining two are Internet Services (MerciYanis, $3M on 2023-10-12) and Information Technology (Declique, $300K on 2020-11-17).
Is there a clear outlier in round size or profile among these rows?
Yes on both dimensions. Declique’s $300K on 2020-11-17 is far smaller than every other disclosed amount in the table (the next-lowest is MerciYanis at $3M on 2023-10-12), making it a size outlier; the only large-scale outlier on the high end is Antabio at $27M (2023-12-12), ahead of EyeLights ($22M) and Alteia ($17M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.